|
Report Date : |
26.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
PHARMACHEMIE B.V. |
|
|
|
|
Registered Office : |
Swensweg 5 2031GA |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
15.03.1944 |
|
|
|
|
Com. Reg. No.: |
34016881 |
|
|
|
|
Legal Form : |
Private Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations |
|
|
|
|
No. of Employees |
565 |
RATING & COMMENTS
|
MIRAs Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Source
: CIA |
Company name PHARMACHEMIE
B.V.
Operative address Swensweg 5
2031GA
Legal form Private Company
Registration number KvK-nummer:
34016881
VAT-number 001012940
Company name Pharmachemie B.V.
Trade names Pharmachemie B.V.
Teva Pharmachemie
Teva Pharmachemie Operations
Operative address Swensweg 5
2031GA
Correspondence address Postbus 552
2003RN
Telephone number 08000228400
Fax number 0235147192
Email address
pch.legal@tevapharmachemie.com
Website www.tevapharmachemie.com
Registration number KvK-nummer:
34016881
Branch number 000016614496
VAT-number 001012940
Status Active
Memorandum 1959-12-23
Establishment date 1944-03-15
Legal form Private Company
Legal person since 1972-04-25
Last proposed admendment 2005-01-07
SBI Manufacture of pharmaceutical
preparations (212)
Manufacture of pharmaceutical preparations
(2120)
Manufacture of pharmaceutical products, no
raw (212001)
Wholesale of pharmaceutical goods (46461)
Other specialised business services (7490)
ISO certified Yes
Exporter Yes
Importer Yes
Branche
organisations BOGIN - Association of Generic Medicines in the Netherlands
KNDB - Royal Dutch
Drugstores Bond
Goal The import and export, wholesale, manufacturing, and doing manufacturing
pharmaceutical products, raw materials and products and the acquisition, provision
and
operating licenses, patents,
patents, trademarks and other forms of
The establishment of industrial property,
participating in, managing, advising
of, checking, working with the conduct of the
management board and the
providing services to other vennnootschappen and businesses, as well as the
finance other companies and enterprises
Companies on same address
Shareholders Teva Pharmaceuticals
Piet Heinkade 107
1019GM
Registration number: 301106250000
Percentage: 100%
Teva Nederland B.V.
Registration number: 340961910000
Stichting Pensioenfonds Pharmachemie
Registration number: 341529420000
Teva Pharma B.V.
Registration number: 300993690001
ratiopharm
Registration number: 300636290002
Liability statements Teva Pharmaceuticals
Piet Heinkade 107
1019GM
Registration number: 301106250000
End date: 2009-12-31
Accounts
ABN Amro Bank NV
Account number: 48.62.11.401
ABN Amro Bank NV
Account number: 43.27.24.478
ING Bank NV
Account number: 6494361
ING Bank NV
Account number: 188985
Active management
Teva Pharmaceuticals
Piet Heinkade 107
1019GM
Registration number: 301106250000
Competence: Jointly authorized
Function: Manager
Starting date: 2006-10-03
E.G.W.H. Loof (Emile Gerardus Wilhelmus Hendr)
Competence: Jointly authorized
Function: Manager
Starting date: 2000-04-14
Date of birth: 1949-06-09, 's-Gravenhage, NL
H.C. Diekema (Hendrik Cornelis)
Competence: Limited authorization
Function: Proxy
Starting date: 2010-07-01
Date of birth: 1963-10-06,
M.T. Prinsen - Fris (Maria Theresia)
Competence: Limited authorization
Function: Proxy
Starting date: 2010-07-01
Date of birth: 1967-02-13,
J.W. van Wijk (Jan Willem)
Competence: Limited authorization
Function: Proxy
Starting date: 2012-07-03
Date of birth: 1962-10-17,
J.M. Maaskant (Johanna Maria)
Competence: Limited authorization
Function: Proxy
Starting date: 2012-07-03
Date of birth: 1963-06-02,
M.A. Ince - Groenhof (Mirjam Anselma)
Competence: Limited authorization
Function: Proxy
Starting date: 2012-07-03
Date of birth: 1965-06-16,
Year 2014 2013 2012
2011 2010
Total 565 560 565
565 565

Description Payments made under regular condition
Remark annual account This company is
not obliged to file its financial statements
Branch (SBI) Manufacture of
basic pharmaceutical products and pharmaceutical preparations (21)
Region Kennemerland
In the
In the region Kennemerland 14 of the
companies are registered with the SBI code 21
In the
The risk of this specific sector in the
The risk of this specific sector in the
region Kennemerland is normal
Functions 10-07-2012: Per
03-07-2012 is gevolmachtigde Denise van Schooten uit functie getreden.
06-07-2012: Per 03-07-2012 is gevolmachtigde
Mirjam Anselma Ince-Groenhof in functie
getreden.
06-07-2012: Per 03-07-2012 is gevolmachtigde
Jan Willem van Wijk in functie getreden.
06-07-2012: Per 03-07-2012 is gevolmachtigde
Johanna Maria Maaskant in functie getreden.
Mergers 04-12-2013: Op
06-11-2013 fusieakte verleden. Verkrijgende rechtspersoon: Pharmachemie
B.V., 34016881 Verdwijnende rechtspersonen:
Farmaver B.V., 34088047 B.V. Pharbita,
35009579 PCH Vastgoed B.V., 30091675 ... Op
06-11-2013 fusieakte verleden. Verkrijgende
rechtspersoon: Pharmachemie B.V., 34016881
Verdwijnende rechtspersonen: IVAX Farma
B.V., 34193015 Cephalon B.V., 17169815.
02-10-2013: Op 30-09-2013 fusievoorstel
gedeponeerd. Verkrijgende rechtspersoon:
Pharmachemie B.V., 34016881 Verdwijnende
rechtspersonen: Farmaver B.V., 34088047
B.V. Pharbita, 35009579 PCH Vastgoed B.V.,
30091675 ... Op 30-09-2013 fusievoorstel
gedeponeerd. Verkrijgende rechtspersoon:
Pharmachemie B.V., 34016881 Verdwijnende
rechtspersonen: IVAX Farma B.V., 34193015
Cephalon B.V., 17169815.
Teva Pharmaceuticals
Piet Heinkade 107
1019GM
Registration number: 301106250000
Teva Pharma B.V.
Computerweg 10
3542DR
Registration number: 300993690000
Pharmachemie Holding B.V.
Swensweg 5
2031GA
Registration number: 301427760000
Pharmachemie B.V.
Swensweg 5
2031GA
Registration number: 340168810000
Cephalon B.V.
Swensweg 5
2031GA
Registration number: 171698150000
Teva Nederland B.V.
Swensweg 5
2031GA
Registration number: 340961910000
Ivax Farma B.V.
Swensweg 5
2031GA
Registration number: 341930150000
Ratiopharm B.V.
Swensweg 5
2031GA
Registration number: 390588030001
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.42 |
|
|
1 |
Rs.100.11 |
|
Euro |
1 |
Rs.79.74 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SCs credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.